CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $154,244 | +21.7% | 10,345 | -10.7% | 0.00% | – |
Q2 2023 | $126,790 | +153.6% | 11,579 | -15.4% | 0.00% | – |
Q3 2021 | $50,000 | -27.5% | 13,684 | -14.0% | 0.00% | – |
Q2 2021 | $69,000 | 0.0% | 15,903 | +3.9% | 0.00% | – |
Q1 2021 | $69,000 | -15.9% | 15,301 | +7.6% | 0.00% | – |
Q4 2020 | $82,000 | +164.5% | 14,224 | -31.2% | 0.00% | – |
Q1 2020 | $31,000 | +55.0% | 20,686 | +106.3% | 0.00% | – |
Q4 2019 | $20,000 | -94.2% | 10,028 | -67.9% | 0.00% | – |
Q3 2018 | $347,000 | -15.8% | 31,276 | +1.9% | 0.00% | – |
Q2 2018 | $412,000 | – | 30,703 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |